RGNT 6-K: Contract win
Filed with the SEC on · accession 0001493152-26-050658
RGNT filed a 6-K (foreign company report) with the SEC on Nov 9, 2026. How foreign companies listed in the US report news and events — like an 8-K for them.
Summary of the filing
Regentis Biomaterials signed an exclusive distribution agreement with AMI Technologies to commercialize its GelrinC product in Israel.
Key details
✦ Ask GOAX AI about this filing — what it means for RGNT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for RGNT?
Click hereFrequently asked questions
What did RGNT file with the SEC on Nov 9, 2026?
RGNT filed a 6-K (Contract win). Regentis Biomaterials signed an exclusive distribution agreement with AMI Technologies to commercialize its GelrinC product in Israel.
What does a contract win mean for RGNT stock?
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
Other RGNT SEC filings
Get alerts when RGNT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days